1. Home
  2. FNWB vs VRCA Comparison

FNWB vs VRCA Comparison

Compare FNWB & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Northwest Bancorp

FNWB

First Northwest Bancorp

HOLD

Current Price

$11.10

Market Cap

96.3M

Sector

Finance

ML Signal

HOLD

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$5.39

Market Cap

88.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNWB
VRCA
Founded
1923
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
96.3M
88.0M
IPO Year
2012
2018

Fundamental Metrics

Financial Performance
Metric
FNWB
VRCA
Price
$11.10
$5.39
Analyst Decision
Buy
Buy
Analyst Count
1
2
Target Price
$13.50
$17.00
AVG Volume (30 Days)
18.3K
102.4K
Earning Date
04-29-2026
05-11-2026
Dividend Yield
0.70%
N/A
EPS Growth
36.00
N/A
EPS
0.04
N/A
Revenue
$176,000.00
$35,577,000.00
Revenue This Year
$19.24
N/A
Revenue Next Year
$8.90
$94.44
P/E Ratio
$281.50
N/A
Revenue Growth
N/A
370.22
52 Week Low
$7.05
$3.28
52 Week High
$12.52
$9.82

Technical Indicators

Market Signals
Indicator
FNWB
VRCA
Relative Strength Index (RSI) 48.17 50.26
Support Level $10.88 $4.52
Resistance Level $11.51 $6.22
Average True Range (ATR) 0.24 0.43
MACD -0.00 0.08
Stochastic Oscillator 24.91 49.60

Price Performance

Historical Comparison
FNWB
VRCA

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It offers various products and services, such as commercial business loans, multi-family real estate loans, auto and consumer loans, transaction accounts, savings and money market accounts, online banking services, etc., focused on the lending, deposit, and money movement needs of individuals, businesses and nonprofit organizations. The Group's operations are mainly focused on serving various communities in Washington State, U.S. Substantially all of its income is derived from a diverse base of commercial, mortgage, and consumer lending activities and investments.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

Share on Social Networks: